600513 联环药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.6396.12110.30311.66110.660
总资产报酬率 ROA (%)0.6942.8654.8475.5775.397
投入资产回报率 ROIC (%)0.8953.6966.4167.4617.323

边际利润分析
销售毛利率 (%)41.49749.37448.13753.34854.631
营业利润率 (%)6.5766.0648.0399.5679.493
息税前利润/营业总收入 (%)7.7317.1239.22310.71810.800
净利润/营业总收入 (%)4.3644.9266.9618.5138.500

收益指标分析
经营活动净收益/利润总额(%)96.08784.49690.236100.86797.452
价值变动净收益/利润总额(%)-3.676-8.117-0.241-1.514-0.941
营业外收支净额/利润总额(%)0.438-0.4530.1491.0612.087

偿债能力分析
流动比率 (X)1.1731.1031.0861.1001.182
速动比率 (X)0.7860.7750.8330.8760.983
资产负债率 (%)50.71547.76546.86747.92845.604
带息债务/全部投入资本 (%)47.17840.40737.12337.35133.651
股东权益/带息债务 (%)108.434145.145167.777166.714196.041
股东权益/负债合计 (%)77.19396.766101.18097.342107.845
利息保障倍数 (X)6.8676.5607.87110.2249.772

营运能力分析
应收账款周转天数 (天)80.14585.52180.90880.47783.813
存货周转天数 (天)124.181124.21394.95995.11695.837